Literature DB >> 23323191

Diabetes and the elderly brain: sweet memories?

Katherine Samaras1, Perminder S Sachdev.   

Abstract

Type 2 diabetes is common in older people and is associated with higher risk of both vascular dementia and Alzheimer's disease. This review examines the evidence for increased risk of dementia and mild cognitive impairment in patients with diabetes and the role of potential confounders. The relationship of diabetes and impaired fasting glucose with brain structure is also reviewed, focusing on longitudinal studies in older people. The pathophysiology underlying cognitive change in type 2 diabetes is examined with reference to vascular disease, hypoglycaemia, inflammation and insulin levels. Implications for clinical care in older people with diabetes are discussed, with a recommendation for cognitive evaluation as a routine part of end-organ, diabetes complication review.

Entities:  

Keywords:  Brain; brain volume; cognition; dementia; diabetes; glucose; impaired fasting glucose; inflammation

Year:  2012        PMID: 23323191      PMCID: PMC3539178          DOI: 10.1177/2042018812469645

Source DB:  PubMed          Journal:  Ther Adv Endocrinol Metab        ISSN: 2042-0188            Impact factor:   3.565


  62 in total

1.  The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons.

Authors:  M N Haan; L Shemanski; W J Jagust; T A Manolio; L Kuller
Journal:  JAMA       Date:  1999-07-07       Impact factor: 56.272

Review 2.  Encephalopathies: the emerging diabetic complications.

Authors:  Anders A F Sima
Journal:  Acta Diabetol       Date:  2010-08-27       Impact factor: 4.280

3.  Progression of cerebral atrophy and white matter hyperintensities in patients with type 2 diabetes.

Authors:  Jeroen de Bresser; Audrey M Tiehuis; Esther van den Berg; Yael D Reijmer; Cynthia Jongen; L Jaap Kappelle; Willem P Mali; Max A Viergever; Geert Jan Biessels
Journal:  Diabetes Care       Date:  2010-03-18       Impact factor: 19.112

4.  Diabetes mellitus and the risk of dementia, Alzheimer's disease and vascular cognitive impairment in the Canadian Study of Health and Aging.

Authors:  Chris MacKnight; Kenneth Rockwood; Erin Awalt; Ian McDowell
Journal:  Dement Geriatr Cogn Disord       Date:  2002       Impact factor: 2.959

5.  Diabetes mellitus and risk of Alzheimer disease and decline in cognitive function.

Authors:  Zoe Arvanitakis; Robert S Wilson; Julia L Bienias; Denis A Evans; David A Bennett
Journal:  Arch Neurol       Date:  2004-05

6.  Severe hypoglycaemia and cognitive impairment in older patients with diabetes: the Fremantle Diabetes Study.

Authors:  D G Bruce; W A Davis; G P Casey; R M Clarnette; S G A Brown; I G Jacobs; O P Almeida; T M E Davis
Journal:  Diabetologia       Date:  2009-07-03       Impact factor: 10.122

7.  Diabetes increases atrophy and vascular lesions on brain MRI in patients with symptomatic arterial disease.

Authors:  Audrey M Tiehuis; Yolanda van der Graaf; Frank L Visseren; Koen L Vincken; Geert Jan Biessels; Auke P A Appelman; L Jaap Kappelle; Willem P T M Mali
Journal:  Stroke       Date:  2008-03-27       Impact factor: 7.914

8.  Retinal microvascular abnormalities and cognitive decline: the ARIC 14-year follow-up study.

Authors:  S R Lesage; T H Mosley; T Y Wong; M Szklo; D Knopman; D J Catellier; S R Cole; R Klein; J Coresh; L H Coker; A R Sharrett
Journal:  Neurology       Date:  2009-09-15       Impact factor: 9.910

9.  Relation of diabetes to mild cognitive impairment.

Authors:  José A Luchsinger; Christiane Reitz; Bindu Patel; Ming-Xin Tang; Jennifer J Manly; Richard Mayeux
Journal:  Arch Neurol       Date:  2007-04

10.  Association between raised inflammatory markers and cognitive decline in elderly people with type 2 diabetes: the Edinburgh Type 2 Diabetes Study.

Authors:  Riccardo E Marioni; Mark W J Strachan; Rebecca M Reynolds; Gordon D O Lowe; Rory J Mitchell; F Gerry R Fowkes; Brian M Frier; Amanda J Lee; Isabella Butcher; Ann Rumley; Gordon D Murray; Ian J Deary; Jackie F Price
Journal:  Diabetes       Date:  2009-12-03       Impact factor: 9.461

View more
  7 in total

Review 1.  Insulin Resistance and Neurodegeneration: Progress Towards the Development of New Therapeutics for Alzheimer's Disease.

Authors:  Suzanne M de la Monte
Journal:  Drugs       Date:  2017-01       Impact factor: 9.546

2.  Brain region-specific alterations in the gene expression of cytokines, immune cell markers and cholinergic system components during peripheral endotoxin-induced inflammation.

Authors:  Harold A Silverman; Meghan Dancho; Angelique Regnier-Golanov; Mansoor Nasim; Mahendar Ochani; Peder S Olofsson; Mohamed Ahmed; Edmund J Miller; Sangeeta S Chavan; Eugene Golanov; Christine N Metz; Kevin J Tracey; Valentin A Pavlov
Journal:  Mol Med       Date:  2015-03-11       Impact factor: 6.354

3.  Clinical Characteristics for the Relationship between Type-2 Diabetes Mellitus and Cognitive Impairment: A Cross-Sectional Study.

Authors:  Yi Zhou; Rong Fang; Li-Hua Liu; Sheng-Di Chen; Hui-Dong Tang
Journal:  Aging Dis       Date:  2015-08-01       Impact factor: 6.745

Review 4.  Obesity and sex interact in the regulation of Alzheimer's disease.

Authors:  V Alexandra Moser; Christian J Pike
Journal:  Neurosci Biobehav Rev       Date:  2015-12-18       Impact factor: 8.989

Review 5.  Association between the Vicious Cycle of Diabetes-Associated Complications and Glycemic Control among the Elderly: A Systematic Review.

Authors:  Muhammad Atif; Quratulain Saleem; Zaheer-Ud-Din Babar; Shane Scahill
Journal:  Medicina (Kaunas)       Date:  2018-10-15       Impact factor: 2.430

6.  Cognitive Impairment in Type 2 Diabetes Mellitus: An Observational Study from Lower Middle-Income Country.

Authors:  Saad B Z Mahmood; Amara Zafar; Aysha Almas
Journal:  Indian J Endocrinol Metab       Date:  2022-06-06

7.  Evidence of altered brain network centrality in patients with diabetic nephropathy and retinopathy: an fMRI study using a voxel-wise degree centrality approach.

Authors:  Yu Wang; Lei Jiang; Xiao-Yu Wang; Weizhe Chen; Yi Shao; Qin-Kai Chen; Jin-Lei Lv
Journal:  Ther Adv Endocrinol Metab       Date:  2019-07-27       Impact factor: 3.565

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.